BeOne Medicines (ONC) Goodwill & Intangibles (2017 - 2026)
BeOne Medicines' (ONC) quarterly Goodwill & Intangibles came in at $61.7 million in Q1 2026, up 23.02% year-on-year from $50.1 million in Q1 2025, and down 1.63% on a QoQ basis from $62.7 million in Q4 2025.
BeOne Medicines (ONC) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
BeOne Medicines (ONC) has 10 years of Goodwill & Intangibles data on file, last reported at $61.7 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 23.02% year-over-year to $61.7 million in Q1 2026; TTM through Mar 2026 was $61.7 million, a 23.02% increase from a year earlier, with the FY2025 full-year figure at $62.7 million, up 22.72% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $61.7 million, down from $62.7 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for ONC reached as high as $64.9 million in Q2 2025 and fell as low as $39.7 million in Q1 2023.
- Historically, Goodwill & Intangibles has averaged $52.1 million across 5 years, with a median of $53.7 million in 2023.
- Across the five-year window, Goodwill & Intangibles soared 851.73% in 2022 and dropped 13.26% in 2023, its largest moves.
- Year by year, Goodwill & Intangibles stood at $40.6 million in 2022, then surged by 40.68% to $57.1 million in 2023, then dropped by 10.58% to $51.1 million in 2024, then grew by 22.72% to $62.7 million in 2025, then dropped by 1.63% to $61.7 million in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $61.7 million in Q1 2026, $62.7 million in Q4 2025, and $63.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.68 Mn |
| Dec 31, 2025 | 62.70 Mn |
| Sep 30, 2025 | 63.58 Mn |
| Jun 30, 2025 | 64.89 Mn |
| Mar 31, 2025 | 50.14 Mn |
| Dec 31, 2024 | 51.10 Mn |
| Sep 30, 2024 | 53.94 Mn |
| Jun 30, 2024 | 53.72 Mn |
| Mar 31, 2024 | 55.17 Mn |
| Dec 31, 2023 | 57.14 Mn |
| Sep 30, 2023 | 53.66 Mn |
| Jun 30, 2023 | 46.90 Mn |
| Mar 31, 2023 | 39.74 Mn |
| Dec 31, 2022 | 40.62 Mn |
| Sep 30, 2022 | 40.85 Mn |
| Jun 30, 2022 | 43.33 Mn |
| Mar 31, 2022 | 45.81 Mn |
| Dec 31, 2021 | 46.68 Mn |
| Sep 30, 2021 | 14.10 Mn |
| Jun 30, 2021 | 12.01 Mn |